Friday, January 29, 2016

New three-drug delivery system shows promise for treatment of metastatic melanoma

›
Researchers have developed a new three-drug delivery system for cancer treatment, especially metastatic melanoma, the deadliest form of sk...
Wednesday, January 27, 2016

Ibrutinib more effective than traditional chemotherapy in older untreated patients with CLL

›
In continuation of my update on  ibrutinib A multi-center, international, randomized, Phase III study of older untreated patients with...
Tuesday, January 26, 2016

XARELTO reduces rates of major bleeding, recurrent blood clots in people with deep vein thrombosis

›
In continuation of my update on  rivaroxaban Janssen Pharmaceuticals, Inc. (Janssen) and its development partner, Bayer Health...
Monday, January 25, 2016

American scientists synthesize glycopolymers that prolong lifetime of healthy cells

›
Glycoproteins such as the mucins are assumed to be heavily involved in oncogenesis and metastasic spread. They are part of a strategy ...
Friday, January 22, 2016

Helsinn one step closer to bringing anamorelin HCI to market for treatment of anorexia, cachexia in NSCLC patients

›
Helsinn, the Swiss pharmaceutical Group focused on building quality cancer care, today announced that the European Medicines Agency (EMA) ...
Thursday, January 21, 2016

Innovative compound with anti-MRSA qualities may help develop new class of antibiotics

›
With global health services increasingly worried about the rise of antibiotic resistant diseases, researchers at Maynooth University h...
Wednesday, January 20, 2016

Novel class of antimicrobials could be effective in fighting drug-resistant MRSA infection

›
A novel class of antimicrobials that inhibits the function of a key disease-causing component of bacteria could be effective in fighting m...
Tuesday, January 19, 2016

Lexicon announces top-line results from TELECAST Phase 3 study of telotristat etiprate

›
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that top-line data from its TELECAST Phase 3 study showed results of te...
Monday, January 18, 2016

Seaweed extract shows promise in treating H. pylori-related diseases, gastric cancer

›
Effective treatments for H. pylori are limited with a rising percentage of treatment failures, primarily due to antibiotic resistanc...
Friday, January 15, 2016

Second-line bosutinib offers ‘durable’ response for chronic phase CML patients

›
In continuation of my update on  bosutinib Four-year results for an ongoing study of second-line bosutinib indicate that the tyr...
Thursday, January 14, 2016

New data shows ALS-008176 drug safe and effective against RSV infection

›
Alios BioPharma, Inc., part of the Janssen Pharmaceutical Companies announced that the New England Journal of Medicine (NEJM) wil...
Wednesday, January 13, 2016

Takeda receives FDA approval for NINLARO (ixazomib) capsules to treat patients with multiple myeloma

›
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the U.S. Food and Drug Administration (FDA) has approved NINLAR...
Tuesday, January 12, 2016

New drug combination may reduce need for complex regimens to treat hepatitis C

›
I n continuation of my update on  sofosbuvir    The prognosis for people with hepatitis C has improved dramatically in the last fe...
1 comment:
Monday, January 11, 2016

Sildenafil drug improves insulin sensitivity in people at risk for diabetes

›
Sildenafil inhibits an enzyme called phosphodiesterase 5 (PDE5), resulting in relaxation of smooth muscle, vasodilation and increas...
Friday, January 8, 2016

Identifying new mechanism for aspirin in cancer prevention

›
In a study published in the journal of  Cancer Epidemiology, Biomarkers, and Prevention , Ulrich and her collaborators used a new techniqu...